{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:43:21Z","timestamp":1794494601435,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The French Journal of Urology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.fjurol.2025.102922","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T11:19:16Z","timestamp":1750504756000},"page":"102922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Microbiome and immunotherapy in bladder cancer: The missing link"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0249-0739","authenticated-orcid":false,"given":"Ali","family":"Bourgi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Bruy\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Rusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.fjurol.2025.102922_bib0140","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102922_bib0145","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology guidelines on non\u2013muscle-invasive bladder cancer (Ta, T1, and CIS)\u00a0\u2013\u00a02022 update","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.fjurol.2025.102922_bib0150","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","article-title":"Bladder cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Powles","year":"2022","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.fjurol.2025.102922_bib0155","first-page":"474","article-title":"Bladder cancer: current problems and future solutions","volume":"70","author":"Kamat","year":"2016","journal-title":"Eur Urol"},{"issue":"6371","key":"10.1016\/j.fjurol.2025.102922_bib0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.fjurol.2025.102922_bib0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"6371","key":"10.1016\/j.fjurol.2025.102922_bib0170","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"issue":"271","key":"10.1016\/j.fjurol.2025.102922_bib0175","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3010473","article-title":"Cancer and the gut microbiota: an unexpected link","volume":"7","author":"Zitvogel","year":"2015","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.fjurol.2025.102922_bib0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.eururo.2015.02.041","article-title":"\u201cSterile urine\u201d and the presence of bacteria","volume":"68","author":"Wolfe","year":"2015","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.fjurol.2025.102922_bib0185","first-page":"651","article-title":"The urinary microbiome in patients with bladder cancer: a systematic review","volume":"53","author":"Hussein","year":"2021","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"10.1016\/j.fjurol.2025.102922_bib0190","first-page":"937","article-title":"Altered urinary microbiome in bladder cancer patients","volume":"103","author":"Liu","year":"2019","journal-title":"Appl Microbiol Biotechnol"},{"issue":"3","key":"10.1016\/j.fjurol.2025.102922_bib0195","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/JCM.02876-13","article-title":"Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder","volume":"52","author":"Ilt","year":"2014","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.fjurol.2025.102922_bib0200","doi-asserted-by":"crossref","first-page":"22.e13","DOI":"10.1016\/j.urolonc.2023.11.003","article-title":"The bladder microbiota is not significantly altered by intravesical BCG therapy","volume":"42","author":"Heidrich","year":"2024","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.fjurol.2025.102922_bib0205","first-page":"299","article-title":"The urinary microbiome: implications in bladder cancer pathogenesis and therapeutics","volume":"37","author":"Bajic","year":"2019","journal-title":"Urol Oncol"},{"issue":"6285","key":"10.1016\/j.fjurol.2025.102922_bib0210","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","article-title":"Population-based metagenomics analysis reveals markers for gut microbiome composition associated with diet and disease","volume":"352","author":"Zhernakova","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.fjurol.2025.102922_bib0215","first-page":"10245","article-title":"Cigarette smoking induces urinary microbiome dysbiosis and promotes bladder cancer in mice","volume":"10","author":"Chen","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.fjurol.2025.102922_bib0220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fcimb.2018.00167","article-title":"Profiling the urinary microbiota in male patients with bladder cancer in China","volume":"8","author":"Wu","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"10.1016\/j.fjurol.2025.102922_bib0225","first-page":"866","article-title":"Dietary fiber and probiotics influence gut microbiota composition and enhance anti-PD-1 efficacy in preclinical cancer models","volume":"39","author":"Spencer","year":"2021","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.fjurol.2025.102922_bib0230","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u00a0\u2014\u00a0a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"issue":"5","key":"10.1016\/j.fjurol.2025.102922_bib0235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"issue":"6510","key":"10.1016\/j.fjurol.2025.102922_bib0240","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.abc3421","article-title":"Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy","volume":"369","author":"Mager","year":"2020","journal-title":"Science"},{"issue":"6529","key":"10.1016\/j.fjurol.2025.102922_bib0250","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"issue":"7741","key":"10.1016\/j.fjurol.2025.102922_bib0245","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41586-019-0878-z","article-title":"A defined commensal consortium elicits CD8T cells and anti-cancer immunity","volume":"565","author":"Tanoue","year":"2019","journal-title":"Nature"},{"issue":"6264","key":"10.1016\/j.fjurol.2025.102922_bib0255","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"issue":"6491","key":"10.1016\/j.fjurol.2025.102922_bib0260","article-title":"Fecal microbiota transplant alters the tumor microenvironment and improves survival in a mouse model of cancer","volume":"368","author":"Wang","year":"2020","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.fjurol.2025.102922_bib0265","doi-asserted-by":"crossref","first-page":"e1434468","DOI":"10.1080\/2162402X.2018.1434468","article-title":"Intestinal microbiota determines the clinical efficacy of immune checkpoint inhibitors in patients with cancer","volume":"7","author":"Derosa","year":"2018","journal-title":"OncoImmunology"},{"issue":"10","key":"10.1016\/j.fjurol.2025.102922_bib0270","first-page":"1223","article-title":"Metagenomic and metabolomic analyses link gut microbiome changes to response to immune checkpoint inhibitors","volume":"23","author":"Frankel","year":"2017","journal-title":"Nat Med"}],"container-title":["The French Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393025000695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950393025000695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T03:57:22Z","timestamp":1759636642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950393025000695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2950393025000695"],"URL":"https:\/\/doi.org\/10.1016\/j.fjurol.2025.102922","relation":{},"ISSN":["2950-3930"],"issn-type":[{"value":"2950-3930","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Microbiome and immunotherapy in bladder cancer: The missing link","name":"articletitle","label":"Article Title"},{"value":"The French Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fjurol.2025.102922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102922"}}